The PROTECT Trial puts into question hypothermia prevention at non-cardiac surgery and assessed whether patients’ body temperatures could be kept at 35.5°C or should be maintained closer to 37 degrees. touchCARDIO spoke to Prof Daniel Sessler (Cleveland Clinic, Cleveland, OH, USA) to discuss his presentation at the American College of Cardiology Annual Meeting 2022 entitled: ‘The PROTECT Trial: Very Mild Perioperative Hypothermia Versus Aggressive Warming and Myocardial Injury After Non-cardiac Surgery’.
Questions
- What was known about the impact of perioperative hypothermia on myocardial injury after non-cardiac surgery? 00:26–1:19
- Could you tell us a little about the hypothesis that is being tested in the PROTECT trial? 01:19-02:06
- What are the eligibility criteria and design of the PROTECT trial? 02:06-02:38
- What have been the findings of the study to date? 02:38-04:22
- What will be the impact of these findings on clinical practice? 04:22-05:51
Speaker Disclosure: Daniel Sessler has no actual or potential conflicts of interest in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the American College of Cardiology Annual Meeting 2022
